IDXG Key Statistics, Chart & Performance
The current stock price of IDXG is 3.92 null. In the past month the price decreased by -11.51%. In the past year, price decreased by -52.31%.
IDXG Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to IDXG. When comparing the yearly performance of all stocks, IDXG is a bad performer in the overall market: 95.5% of all stocks are doing better.
IDXG Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to IDXG. IDXG has a bad profitability rating. Also its financial health evaluation is rather negative.
IDXG Financial Highlights
Over the last trailing twelve months IDXG reported a non-GAAP Earnings per Share(EPS) of -4.9399999999999995. The EPS decreased by -25.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -106.8% | ||
| ROA | -56.81% | ||
| ROE | N/A | ||
| Debt/Equity | -0.16 |
IDXG Forecast & Estimates
IDXG Ownership
About IDXG
Company Profile
Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.
Company Info
Interpace Diag Group
MORRIS CORPORATE CENTER 1 BUILDING C 300 INTERPACE PARKWAY
PARSIPPANY NJ 07054
CEO: Jack E. Stover
Phone: 855-776-6419
Interpace Diag Group / IDXG FAQ
Can you describe the business of Interpace Diag Group?
Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.
What is the stock price of Interpace Diag Group today?
The current stock price of IDXG is 3.92 null. The price increased by 0.51% in the last trading session.
Does IDXG stock pay dividends?
IDXG does not pay a dividend.
How is the ChartMill rating for Interpace Diag Group?
IDXG has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists IDXG stock?
IDXG stock is listed on the Nasdaq exchange.
What is the market capitalization of IDXG stock?
Interpace Diag Group (IDXG) has a market capitalization of 16.09M null. This makes IDXG a Nano Cap stock.